Skip to main content
Premium Trial:

Request an Annual Quote

Genzyme

Premium
Genzyme this week launched its cystic fibrosis gene-sequencing test. The company said the test can detect approximately 98 percent of the more than 1,200 disease-causing mutations in the CFTR gene.
 
Most genetic CF testing is performed by mutation panels, which detect the most common CFTR mutations. CF gene sequencing detects the most common mutations, as well as less common mutations not included in the available mutation panels.
 
Genzyme’s CF testing program includes CFplus, an analysis of 97 mutations that provides high CF detection rates for the pan-ethnic US population in five to eight days. This test is available on blood serum, buccal swab, and mouthwash samples.
 
CF gene sequencing offers a “more comprehensive” answer in two to three weeks, according to Genzyme, which offers physicians access to board-certified clinical molecular geneticists to discuss test results and genetic counselors for patients to discuss what testing means for them.

Filed under

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.